| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/21/2009 | CN101559218A Composition with function of increasing bone density |
| 10/21/2009 | CN101559217A Oral administration route of 7P peptide and application thereof to prevention or treatment of nephritis |
| 10/21/2009 | CN101559216A Amino acid composition capable of protecting kidney and liver as well as promoting growth for animal and preparation technique thereof |
| 10/21/2009 | CN101559215A Skin physiology repair liquid and preparation method thereof |
| 10/21/2009 | CN101559214A Composition having effect of enhancing immunity function and usage thereof |
| 10/21/2009 | CN101559072A Application of polycation compound in related angiogenesis diseases |
| 10/21/2009 | CN101559041A Polypeptide medicament sustained release microsphere or microcapsule preparation with uniform grain size and preparation method thereof |
| 10/21/2009 | CN101559039A Method for producing nattokinase liposome from phytosterol |
| 10/21/2009 | CN100551931C T cell receptor display |
| 10/21/2009 | CN100551930C Peptides modulating caspase activation |
| 10/21/2009 | CN100551445C Self assembled precusor liposome containing hard soluble medicine and its preparation method |
| 10/21/2009 | CN100551440C Therapeutic ultrasonic microvesicle for tumour ultrasonic therapy and its preparing method |
| 10/21/2009 | CN100551439C Long acting injectable insulin composition and methods of making and using thereof |
| 10/21/2009 | CN100551438C Use of kerato cell growth factor-2 in treatment of chronic cervicitis medicine |
| 10/21/2009 | CN100551437C Purposes of epididymis specific antibiotic peptide Bin1b in spermiotiliosis |
| 10/21/2009 | CN100551436C Anti-hepatitis B virus ascidians polypeptide medicine composition and the preparing method |
| 10/20/2009 | US7605233 Tumour necrosis factor binding ligands |
| 10/20/2009 | US7605231 Having organic compound as graft chain and high-molecular weight micelle containing the gelatin derivative; as organic compound, a low molecular weight compound such as succinic acid, ethylenediamine, or high-molecular weight compound such as polyethylene glycol can be used; adhesion preventing membrane |
| 10/20/2009 | US7605229 Chimera; FC fragments; antibody overexpression; immunoglobulins; gene therapy |
| 10/20/2009 | US7605228 Insecticidal toxin complex fusion proteins |
| 10/20/2009 | US7605227 Immunogens; plasmids; directly interact with major histocompatability complex, improving immunology |
| 10/20/2009 | US7605226 Meltrins |
| 10/20/2009 | US7605166 Synergistic mixture of methotrexate and integrin antigen or antibody |
| 10/20/2009 | US7605150 Drug therapy for Celiac Sprue |
| 10/20/2009 | US7605142 used to treat tumor (osteosarcoma or Ewing's sarcoma); restenosis |
| 10/20/2009 | US7605140 Endothelial growth factors; antiischemic agents; neovascularization |
| 10/20/2009 | US7605138 Nucleic acid compositions for stimulating immune responses |
| 10/20/2009 | US7605133 Isolated peptides to treat alpha-synuclein diseases |
| 10/20/2009 | US7605132 Protective factors against inflammation, burns and noxious stimuli |
| 10/20/2009 | US7605131 EML4-ALK fusion gene |
| 10/20/2009 | US7605130 Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction |
| 10/20/2009 | US7605129 Splice variant of human placental growth hormone |
| 10/20/2009 | US7605128 Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia |
| 10/20/2009 | US7605127 Truncated hepatocyte growth factor variant protein HGF/NK2 |
| 10/20/2009 | US7605126 Acylaminoheteroaryl hepatitis C virus protease inhibitors |
| 10/20/2009 | US7605125 Anticancer agents |
| 10/20/2009 | US7605124 an ejection liquid for stably ejecting a solution containing at least one kind of insulin ( polyoxyethylene glycol or polyvinyl alcohol modified insulin), citric acid and a surfactant; ejecting the liquid by a thermal inkjet system |
| 10/20/2009 | US7605123 Fatty acid formulations for oral delivery of proteins and peptides, and uses thereof |
| 10/20/2009 | US7605122 sublingual formulations for promoting weight loss in a human on low caloric diet ,comprising reconstituted hCG, having a pH in the range of about 7.0 to 8.0, sodium carbonate buffer, an absorption-enhancing compound (corn oil, mineral oil), and a taste-enhancing agent (glycerin) |
| 10/20/2009 | US7605121 Oligopeptide lyophilisate, their preparation and use |
| 10/20/2009 | US7605120 peptides and/or conjugated peptides may be used as therapeutics or prophylactics for the treatment of diseases mediated by B1 activation, including inflammation and chronic pain states of inflammatory and neuropathic origin, septic shock, arthritis, osteoarthritis, angina, asthma, allergic rhinitis |
| 10/20/2009 | US7605119 Administering an atypical form of protein kinase C, such as PKM zeta or PKC iota/lambda; also treating brain and spinal cord injuries |
| 10/20/2009 | US7604993 Generation of neuronal cells for use in the treatment of nervous system disorders; preparing nutrient broth contain nerve growth factor, inoculating with cells, producing neuronal precursor cells or glial precursor cells |
| 10/20/2009 | US7604970 Variants of the PapM polypeptide of bacteria of the Streptomyces genus |
| 10/20/2009 | US7604961 VP1 of foot-and-mouth disease virus |
| 10/20/2009 | US7604958 Transfection, culturing; electrophoresis |
| 10/20/2009 | US7604955 Detection of peptides which induce cytotoxic t-lymphocytes; provide imunoglobulin test peptide, incubate with cells, monitor mammalian cytotoxic T- lymphocyte response, isolate peptide which induce response |
| 10/20/2009 | US7604931 Cripto mutant and uses thereof |
| 10/20/2009 | US7604811 Inducing an immune response in mammals comprising administering an antigenic synthetic peptide containing Colonization FactorAntigen/I pilus protein T-cell epitopes encapsulated within a biodegradable matrix of glycolic acid-lactic acid copolymer; amino acid sequences; intestinal bioavailability |
| 10/20/2009 | US7604810 Conserved Neisserial antigens |
| 10/20/2009 | US7604804 Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric gp120 |
| 10/20/2009 | US7604797 Compositions and methods for treating burns |
| 10/20/2009 | CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection |
| 10/20/2009 | CA2481593C Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin |
| 10/20/2009 | CA2451923C Botulinum toxin in the treatment or prevention of acne |
| 10/20/2009 | CA2446712C System for osmotic delivery of pharmaceutically active agents |
| 10/20/2009 | CA2378428C Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes |
| 10/20/2009 | CA2376894C Pharmaceutical composition comprising a protein and an ectoine |
| 10/20/2009 | CA2370314C Differentially acting op detoxifying sponges |
| 10/20/2009 | CA2360110C Sustained release salts of pharmaceutically active peptides and their production |
| 10/20/2009 | CA2341354C Dengue viruses that are replication defective in mosquitos for use as vaccines |
| 10/20/2009 | CA2336663C Coumarin and related aromatic-based polymeric prodrugs |
| 10/20/2009 | CA2330363C Diacylglycerol o-acyltransferase |
| 10/20/2009 | CA2330183C Novel insulin analogs with enhanced zinc binding |
| 10/20/2009 | CA2314685C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride |
| 10/20/2009 | CA2250085C Modulators of tnf receptor associated factor (traf), their preparation and use |
| 10/18/2009 | CA2649477A1 Composition and method for promoting internal health and external appearance |
| 10/15/2009 | WO2009126898A2 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus( (jev) and their use |
| 10/15/2009 | WO2009126842A1 Combination of hgf inhibitor and pten agonist to treat cancer |
| 10/15/2009 | WO2009126840A1 Combination of hgf inhibitor and hedgehog inhibitor to treat cancer |
| 10/15/2009 | WO2009126742A2 Enzyme mediated delivery system |
| 10/15/2009 | WO2009126725A1 Method of modulating neovascularization |
| 10/15/2009 | WO2009126659A1 Neutralization of gm-csf for the treatment of heart failure |
| 10/15/2009 | WO2009126502A2 Methods of inhibiting and treating biofilms using glycopeptide antibiotics |
| 10/15/2009 | WO2009126346A2 Methods for prevention and treatment of infections with supraphysiological doses of mannan-binding lectin (mbl) and ficolin-mbl fusion proteins |
| 10/15/2009 | WO2009126153A1 Telomerase suppressor (lela1) compositions and methods for diagnosis and treatment of cancer in a mammalian subject |
| 10/15/2009 | WO2009126132A1 Formulations and methods for modulating satiety |
| 10/15/2009 | WO2009125859A1 Drug, dental material, and screening method |
| 10/15/2009 | WO2009125804A1 Screening method |
| 10/15/2009 | WO2009125424A2 Peptidomimetics with glucagon antagonistic and glp-1 agonistic activities |
| 10/15/2009 | WO2009125423A2 Compositions useful for the treatment of diabetes and other chronic disorder |
| 10/15/2009 | WO2009124971A2 Novel compositions and their use |
| 10/15/2009 | WO2009124853A1 New ruthenium complexes as catalysts for metathesis reactions |
| 10/15/2009 | WO2009124754A1 Compositions containing cyclic peptides and methods of use |
| 10/15/2009 | WO2009124721A1 Novel antimicrobial peptides |
| 10/15/2009 | WO2009124503A1 Use of protein extract from plant seed embryo and composition thereof |
| 10/15/2009 | WO2009124386A1 Combination therapy for the treatment of bacterial infections |
| 10/15/2009 | WO2009124362A1 Suppressor of the endogenous interferon- gamma |
| 10/15/2009 | WO2009124353A1 Modified cpn10 and prr signalling |
| 10/15/2009 | WO2009124333A1 Modified chaperonin 10 and prr signaling |
| 10/15/2009 | WO2009102792A3 Human collagen products and methods for producing human collagen products |
| 10/15/2009 | WO2009102367A3 Tight junction protein modulators and uses thereof |
| 10/15/2009 | WO2009094636A3 Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway |
| 10/15/2009 | WO2009083686A9 Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes |
| 10/15/2009 | WO2009078931A9 Irf as a tumor suppressor and uses thereof |
| 10/15/2009 | WO2009074796A3 Inhibition of scarring using tgf-beta 3 |
| 10/15/2009 | WO2009074271A8 Peptides modulators of tubulin polymerisation |
| 10/15/2009 | WO2009054725A3 Means and methods for counteracting muscle disorders |
| 10/15/2009 | WO2009052454A3 Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss |
| 10/15/2009 | WO2009043465A3 Use of beta-endorphin as a therapeutic agent |